24
19
1
49
2
2
2c
1b
1d
18
2a
5c
1d
2 29
1d
25
Kevin R. Fox
77
5c
Emeritus Professor CE of Medicine (Hematology-Oncology)
7
5f
Department: Medicine
4
1
b
1d
46
Contact information
4e
4
3
3
3
2
4
b
1f
4e
Division of Hematology Oncology
2d Perelman Center for Advanced Medicine
22 10th Floor, South Pavilion
3e 3400 Civic Center Boulevard
Philadelphia, PA 19104
26
2d Perelman Center for Advanced Medicine
22 10th Floor, South Pavilion
3e 3400 Civic Center Boulevard
Philadelphia, PA 19104
2e
Office: 215-662-7469
32 Fax: 215-662-7352
24
93
32 Fax: 215-662-7352
24
Email:
krfox2@mail.med.upenn.edu
12
krfox2@mail.med.upenn.edu
13
Education:
21 9 A.B. c
3e Princeton University, Magna Cum Laude, 1977.
21 9 M.D. e (?) c
31 Johns Hopkins University, 1981.
c
3
3
3
3
8b
Permanent link21 9 A.B. c
3e Princeton University, Magna Cum Laude, 1977.
21 9 M.D. e (?) c
31 Johns Hopkins University, 1981.
c
2 29
21
1e
1d
24
2b
29
27
23
14b Santiago, J, Wu, L, Harris, E, Fox, K, Schultz, D, Glick, J, and Solin, L.: Fifteen year results of breast conserving surgery and definitive irradiation for stage I and II breast carcinoma: The University of Pennsylvania experience. Submitted January 2003.
79 Manne, S, Ostroff, J, Sherman, M, Glassman, M, Ross, S, Goldstein, L, Fox, K. cb : Buffering effects for family and friend support on associations between partner unsupportive behaviors and coping among women with breast cancer. Accepted for publication, J Soc Pers Rel 1a 2002.
126 Santiago, R, Wu, L, Schultz, D, Harris, E, Fox, K, Glick, J, Solin, L. : Fifteen-year results of breast-conserving surgery and definitive irradiation for stage I and II breast cancer: the University of Pennsylvania experience. Proc ASCO 2 23 21: 39a, 2002.
d9 Miller, W., DeMichele, A, Fox, K, Glick, J, Batist, G, Welles, L.: A phase I/II dose escalating trial of liposomal doxorubicin (TLC D-99, Myocet) in combination with 5d paclitaxel (Taxol, T) for patients (pts) wit metastatic breast cancer (MBC). Proc ASCO 23 21: 31b, 2002.
e5 Moore, HCF, and Fox, K. : Hormonal therapy. Breast Cancer: A multidisciplinary approach. Torosian,M. (eds.). Humana, Totowa, NJ, Page: 161-174, 2002.
dd Fox, K: Ascites. Clinical Practice of Hematology and Oncology. Furie, B, Mayer, R, Cassileth, P, and Atkins, M. (eds.). Saunders, in press, 2002.
189 Chang, J, Vines, E, Bertsch, H, Fraker, D, Czerniecki, B, Rosato, E, Tomaszewski, J, Conant, E, Orel, S, Schuchter, L, Fox, K, Zieber, N, Glick, J, Solin, L.: The impact Of a multidisciplinary breast cancer clinic on patient management decisions: The University of Pennsylvania experience. Cancer 91: 1231-1237, 2001.
d1 Fox, KR, Ball, J, Mick, R, and Moore, HC. : Preventing chemotherapy-associated amenorrhea (CRA) with leuprolide in young women with early-stage breast cancer. 32 Proc ASCO 20: 25a, 2001.
127 Ball, J, and Fox, KR. : Age-associated incidence of chemotherapy-related amenorhea (CRA) following adjuvant doxorubicin, cyclophosphamide, and paclitaxel (AC/TAXOL) in early-stage breast cancer. Proc ASCO 20: 16b, 2001.
2c
7
1d
1f
Selected Publications
108 Lo Re, V, Fox, K, Ferrari, V, Kossev, P, and Kostman, J. : Hypereosinophilia associated with Cardiac Rhabdomyosarcoma, accepted for publication. American Journal of Hematology January 2003.14b Santiago, J, Wu, L, Harris, E, Fox, K, Schultz, D, Glick, J, and Solin, L.: Fifteen year results of breast conserving surgery and definitive irradiation for stage I and II breast carcinoma: The University of Pennsylvania experience. Submitted January 2003.
79 Manne, S, Ostroff, J, Sherman, M, Glassman, M, Ross, S, Goldstein, L, Fox, K. cb : Buffering effects for family and friend support on associations between partner unsupportive behaviors and coping among women with breast cancer. Accepted for publication, J Soc Pers Rel 1a 2002.
126 Santiago, R, Wu, L, Schultz, D, Harris, E, Fox, K, Glick, J, Solin, L. : Fifteen-year results of breast-conserving surgery and definitive irradiation for stage I and II breast cancer: the University of Pennsylvania experience. Proc ASCO 2 23 21: 39a, 2002.
d9 Miller, W., DeMichele, A, Fox, K, Glick, J, Batist, G, Welles, L.: A phase I/II dose escalating trial of liposomal doxorubicin (TLC D-99, Myocet) in combination with 5d paclitaxel (Taxol, T) for patients (pts) wit metastatic breast cancer (MBC). Proc ASCO 23 21: 31b, 2002.
e5 Moore, HCF, and Fox, K. : Hormonal therapy. Breast Cancer: A multidisciplinary approach. Torosian,M. (eds.). Humana, Totowa, NJ, Page: 161-174, 2002.
dd Fox, K: Ascites. Clinical Practice of Hematology and Oncology. Furie, B, Mayer, R, Cassileth, P, and Atkins, M. (eds.). Saunders, in press, 2002.
189 Chang, J, Vines, E, Bertsch, H, Fraker, D, Czerniecki, B, Rosato, E, Tomaszewski, J, Conant, E, Orel, S, Schuchter, L, Fox, K, Zieber, N, Glick, J, Solin, L.: The impact Of a multidisciplinary breast cancer clinic on patient management decisions: The University of Pennsylvania experience. Cancer 91: 1231-1237, 2001.
d1 Fox, KR, Ball, J, Mick, R, and Moore, HC. : Preventing chemotherapy-associated amenorrhea (CRA) with leuprolide in young women with early-stage breast cancer. 32 Proc ASCO 20: 25a, 2001.
127 Ball, J, and Fox, KR. : Age-associated incidence of chemotherapy-related amenorhea (CRA) following adjuvant doxorubicin, cyclophosphamide, and paclitaxel (AC/TAXOL) in early-stage breast cancer. Proc ASCO 20: 16b, 2001.
2c
44
23
Back to Top
1b
1d
18